Cosmo I Building Health Confidence

We are building health confidence through our work at the intersection of science and technology in the spaces of MedTech AI, dermatology, gastroenterology, and

[Cosmo I Building Health Confidence @CosmoConfidence]

For three decades we’ve worked at the intersection of science, tech & AI to help patients and professionals live with confidence. None of this would have been possible without our amazing team of scientists, technologists and experts.

[Cosmo I Building Health Confidence @CosmoConfidence]

New research will be presented at @WCHRKorea

Oral presentations by Dr. Maria Hordinsky: May 30 | 13:43-13:53 KST May 31 | 11:08-11:23 KST

Poster presentations available May 28-31
The data presented is related to ongoing scientific research.
#WCHR2026 #Dermatology

[Cosmo I Building Health Confidence @CosmoConfidence]

At Cosmo, our work in gut health starts here: with the real people behind every data point. Understanding IBD more deeply is how we move science forward.
#IBDAwareness #IBDHasNoBorders #GutHealth

[Cosmo I Building Health Confidence @CosmoConfidence]

IBD is invisible. Its impact isn't. On #WorldIBDDay, let's talk about what 5 million people live with every day.

[Cosmo I Building Health Confidence @CosmoConfidence]

Crohn's Disease and Ulcerative Colitis cause symptoms others can't see — severe abdominal pain, persistent diarrhoea, extreme fatigue. But their effect on daily life, relationships and emotional wellbeing is profound.

[Cosmo I Building Health Confidence @CosmoConfidence]

CEO @giovannidinapol: "This milestone reflects both strong execution and a clear strategic focus [...] targeted delivery technologies designed to act locally at the site of disease."

#ClinicalTrial #Gastroenterology #IBD

[Cosmo I Building Health Confidence @CosmoConfidence]

Patient enrolment complete. Our Phase II trial evaluating rifamycin enema — an investigational therapy for distal ulcerative colitis and ulcerative proctitis — has reached a key milestone.
https://t.co/l4chMOdWQB

[Cosmo I Building Health Confidence @CosmoConfidence]

77 patients enrolled across 24 European sites, on schedule. Topline results expected fall 2026.

[Cosmo I Building Health Confidence @CosmoConfidence]

We will be presenting new research at @SocInvestDerm #SIDChicago26.
Poster #1054

Title: Clascoterone topical solution 5% modulates androgen receptor-regulated proteins in the secretory proteome of male pattern hair loss The data presented relate to ongoing scientific research.

[Cosmo I Building Health Confidence @CosmoConfidence]

#ICYMI: We announced positive 12-month data results from the SCALP 1 and SCALP 2 studies evaluating clascoterone 5% topical solution in male #HairLoss

Read more: https://t.co/dT4KeV6Gjr #Cosmo #ClinicalTrial #PatientCare #Innovation #AndrogeneticAlopecia

[Cosmo I Building Health Confidence @CosmoConfidence]

Our CFO, Svetlana Sigalova, will hold will hold virtual meetings with during the @𝗞𝗲𝗽𝗹𝗲𝗿 𝗖𝗵𝗲𝘂𝘃𝗿𝗲𝘂𝘅 𝗦𝘄𝗶𝘀𝘀 𝗦𝗲𝗺𝗶𝗻𝗮𝗿.
Connect with us, please reach out to our #InvestorRelations team to arrange a meeting https://t.co/TZgHkFNC5d

#Cosmo #InvestorRelations

[Cosmo I Building Health Confidence @CosmoConfidence]

#DDW2026 reinforced the direction of innovation in gastrointestinal health.
If you missed our poster presentation, you can view it here: https://t.co/4RLktbTEh5

It’s been great to see the field’s momentum continue to grow.

#DDW2026 #Gastroenterology #Research #DigestiveHealth

[Cosmo I Building Health Confidence @CosmoConfidence]

Our CFO, Svetlana Sigalova, will hold one-to-one meetings with investors during the 𝗧𝗣 𝗜𝗖𝗔𝗣 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲

Connect with us, please reach out to our #InvestorRelations team to arrange a meeting https://t.co/TZgHkFO9UL

[Cosmo I Building Health Confidence @CosmoConfidence]

#𝗗𝗗𝗪𝟮𝟬��𝟲 is underway and we presented our poster:
Low systemic absorption of rifamycin sv mmx® in compensated cirrhosis: a pharmacokinetic analysis of a double-blind, placebo-controlled trial.”

The study explores the pharmacokinetic profile of rifamycin SV MMX®

[Cosmo I Building Health Confidence @CosmoConfidence]

Get familiar with an often overlooked chronic condition https://t.co/goJkRsC10X

#AndrogeneticAlopecia (AGA) impacts millions of men worldwide, yet it is often under-recognized and misunderstood.

#PatientImpact

[Cosmo I Building Health Confidence @CosmoConfidence]

📍 May 2, 2026 | 2:00 PM CDT
Abstract Lecture
“Cirrhosis and Vascular Diseases of the Liver”

[Cosmo I Building Health Confidence @CosmoConfidence]

See you at #𝗗𝗗𝗪𝟮𝟬𝟮𝟲
We are looking forward to joining the #gastroenterology community.

Don’t miss:
𝗠𝗮𝘆 𝟯, 𝟮𝟬𝟮𝟲 | 𝟭𝟮:𝟯𝟬 𝗣𝗠 𝗖𝗗𝗧
Our poster presentation: “Low Systemic Absorption of Rifamycin SV MMX® in Compensated Cirrhosis”

#ClinicalResearch

[Cosmo I Building Health Confidence @CosmoConfidence]

Also see the results of important scientific collaborations:

📍May 2, 2026 | 12:30 PM CDT
ePoster Showcase
“Rifamycin improves grip strength and exercise frequency in a mouse model of chronic liver disease and sarcopenia, which requires gut microbes for action.”

[Cosmo I Building Health Confidence @CosmoConfidence]

For many men, the impact of #AndrogeneticAlopecia (AGA) is deeply personal.

Hear from dermatologists about the patient burden of AGA and check out our AGA awareness page for more information on the patient impact.

#hairloss